Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 8, 2017, Pages 1373-1380

  Huang, Y C ^a   Huang, Y W ^b   Lin, Y T ^a,b   Wang, F D ^a,b   Chan, Y J ^a,b   Yang, T C ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; DORIPENEM; ERTAPENEM; FLOMOXEF; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TEICOPLANIN; TIGECYCLINE; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; CLINICAL OUTCOME; DRUG EXPOSURE; ELIZABETHKINGIA MENINGOSEPTICA; EPSILOMETER TEST; FEMALE; FOLEY BALLOON CATHETER; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; IN VITRO STUDY; INDEPENDENT VARIABLE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY RATE; NEUTROPENIA; PATIENT ISOLATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; STRAIN IDENTIFICATION; SURVIVAL; TAIWAN; ADULT; BACTEREMIA; CHRYSEOBACTERIUM; DRUG EFFECTS; FLAVOBACTERIACEAE INFECTION; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; APACHE; BACTEREMIA; CHRYSEOBACTERIUM; DRUG RESISTANCE, BACTERIAL; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; LEVOFLOXACIN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME;

EID: 85014575776     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-017-2942-7     Document Type: Article

References (22)

1. Bloch KC, Nadarajah R, Jacobs R (1997) Cryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Medicine 76:30–41
2. Moore LS, Owens DS, Jepson A et al (2016) Waterborne Elizabethkingia meningoseptica in Adult Critical Care. Emerg Infect Dis 22:9–17
3. Balm MN, Salmon S, Jureen R et al (2013) Bad design, bad practices, bad bugs: frustrations in controlling an outbreak of Elizabethkingia meningoseptica in intensive care units. J Hosp Infect 85:134–140
4. Jean SS, Lee WS, Chen FL, Ou TY, Hsueh PR (2014) Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections. J Hosp Infect 86:244–249
5. Ceyhan M, Yildirim I, Tekeli A et al (2008) A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infect Control 36:453–457
6. Maraki S, Scoulica E, Manoura A, Papageorgiou N, Giannakopoulou C, Galanakis E (2009) A Chryseobacterium meningosepticum colonization outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 28:1415–1419
7. Hoque SN, Graham J, Kaufmann ME, Tabaqchali S (2001) Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect 47:188–192
8. Lin YT, Chan YJ, Chiu CH et al (2009) Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan. Int J Antimicrob Agents 34:100–101
9. Gonzalez LJ, Vila AJ (2012) Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-beta-lactamase BlaB. Antimicrob Agents Chemother 56:1686–1692
10. Bellais S, Poirel L, Naas T, Girlich D, Nordmann P (2000) Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob Agents Chemother 44:1–9
11. Lin YT, Chiu CH, Chan YJ et al (2009) Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis 41:628–634
12. Lin PY, Chen HL, Huang CT, Su LH, Chiu CH (2010) Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Int J Antimicrob Agents 36:436–440
13. Hsu MS, Liao CH, Huang YT et al (2011) Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. Eur J Clin Microbiol Infect Dis 30:1271–1278
14. Hung PP, Lin YH, Lin CF, Liu MF, Shi ZY (2008) Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 41:137–144
15. Kirby JT, Sader HS, Walsh TR, Jones RN (2004) Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997–2001). J Clin Microbiol 42:445–448
16. Friedman ND, Kaye KS, Stout JE et al (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797
17. Wu HS, Wang FD, Tseng CP, Wu TH, Lin YT, Fung CP (2012) Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan. J Infect 64:162–168
18. CLSI (2012) Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA
19. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ (2014) Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 20:1170–1175
20. Hagiya H, Ogawa H, Takahashi Y, Hasegawa K, Iwamuro M, Otsuka F (2015) A nephrostomy-associated urinary tract infection caused by Elizabethkingia meningoseptica. Intern Med 54:3233–3236
21. Lee SW, Tsai CA, Lee BJ (2008) Chryseobacterium meningosepticum sepsis complicated with retroperitoneal hematoma and pleural effusion in a diabetic patient. J Chin Med Assoc 71:473–476
22. Abat C, Desboves G, Olaitan AO et al (2015) Increasing burden of urinary tract infections due to intrinsic colistin-resistant bacteria in hospitals in Marseille, France. Int J Antimicrob Agents 45:144–50